PDS Biotechnology shares declined after it issued an update about a cancer study with a combination of Versamune HPV and pembrolizumab and reported quarterly results. The stock was down 18%, to $2.25, ...
A recent health awareness program at MD Public School in Varanasi, organized by IMS BHU and Mamta Health Institute, educates adolescent girls on menstrual hygiene, balanced nutrition, and the ...
The company has discontinued the Phase I/II trial of its only clinical candidate due to a potential “unfavourable ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback